Takeda Pharmaceutical Li... (TAK)
15.02
-0.17 (-1.12%)
At close: Mar 24, 2025, 3:59 PM
14.88
-0.95%
After-hours: Mar 24, 2025, 08:00 PM EDT
-1.12% (1D)
| Bid | 14.51 |
| Market Cap | 47.62B |
| Revenue (ttm) | 9,169.8B |
| Net Income (ttm) | 416.66B |
| EPS (ttm) | 0.44 |
| PE Ratio (ttm) | 34.14 |
| Forward PE | 25.27 |
| Analyst | n/a |
| Ask | 15.25 |
| Volume | 978,373 |
| Avg. Volume (20D) | 1,773,963 |
| Open | 15.09 |
| Previous Close | 15.19 |
| Day's Range | 15.00 - 15.13 |
| 52-Week Range | 12.58 - 15.31 |
| Beta | 0.41 |
About TAK
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Reves...
Sector Healthcare
IPO Date Jan 5, 2010
Employees 49,281
Stock Exchange NYSE
Ticker Symbol TAK
Website https://www.takeda.com
3 weeks ago
+2.98%
Takeda Pharmaceutical shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+2.93%
Takeda Pharmaceutical shares are trading higher after the company reported better-than-expected Q3 sales results. Also, the company announced a new CEO and share buyback program.
